JPH09110634A - Skin protecting agent and its production - Google Patents

Skin protecting agent and its production

Info

Publication number
JPH09110634A
JPH09110634A JP26735995A JP26735995A JPH09110634A JP H09110634 A JPH09110634 A JP H09110634A JP 26735995 A JP26735995 A JP 26735995A JP 26735995 A JP26735995 A JP 26735995A JP H09110634 A JPH09110634 A JP H09110634A
Authority
JP
Japan
Prior art keywords
chitosan
solution
skin
squid
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP26735995A
Other languages
Japanese (ja)
Other versions
JP2790786B2 (en
Inventor
Toshio Sato
利夫 佐藤
Hitoshi Matsumoto
仁 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISHIYOKU DOUGENSHIYA KK
Original Assignee
ISHIYOKU DOUGENSHIYA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISHIYOKU DOUGENSHIYA KK filed Critical ISHIYOKU DOUGENSHIYA KK
Priority to JP7267359A priority Critical patent/JP2790786B2/en
Publication of JPH09110634A publication Critical patent/JPH09110634A/en
Application granted granted Critical
Publication of JP2790786B2 publication Critical patent/JP2790786B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a skin protecting agent consisting of a neutral solution of a chitosan, good in feeling in use and high in safety, while holding a humidity maintaining property. SOLUTION: This skin protecting agent is obtained by dissolving a highly deacetylated chitosan, preferably a squid chitosan having >=75% deacetylation ratio, with 0.01-5wt.% organic acid buffer solution (e.g.; glutamic acid) and then neutralizing with the addition of an aqueous alkaline solution (e.g.; NaOH) to prepare a preparation fitted to pH4.5-6.5. It is prepared as a lotion, cream, etc. In contrast to the chitosan derived from a crab or a shrimp induces an allergy, the squid chitosan does not induce the allergy and is preferable in view of its safety. The chitosan as an inexpensive natural polymer is used as an industrial waste water treating agent, a growth promoter for agricultural products, a covering membrane for an injured skin, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は皮膚保護剤およびそ
の製造方法に関する。
TECHNICAL FIELD The present invention relates to a skin protective agent and a method for producing the same.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】化粧
品あるいは外用医薬品の剤型としてローション、クリー
ム、軟膏などが汎用されるが、これらの製品に保湿性を
付与することを目的に種々の吸湿性の高い物質が保湿剤
として用いられている。このように保湿剤として使用さ
れ得るための重要な物性である吸湿能力の高い物質に
は、有機物、無機物を併せるとかなりの種類がある。し
かしながら、これらの物質を実際に保湿剤として使用す
るに際しては、安全性に優れていること、製品の形態安
定性を損なわないこと、用途等に制限が無いこと、使用
感が優れていることなどが必要とされる。
2. Description of the Related Art Lotions, creams, ointments, and the like are widely used as cosmetic or topical pharmaceutical preparations, but various hygroscopic substances are provided for the purpose of imparting moisture retention to these products. High moisturizers are used as humectants. As described above, there are considerable types of substances having high moisture absorption ability, which are important physical properties that can be used as a humectant, including organic substances and inorganic substances. However, when these substances are actually used as humectants, they are excellent in safety, do not impair the form stability of products, have no restrictions on applications, etc., and have excellent usability. Is required.

【0003】一般に用いられている保湿剤としては、乳
酸ナトリウム、ピロリドンカルボン酸ナトリウム等の有
機酸塩類;グリセリン、ソルビトール、プロピレングリ
コール等の多価アルコール類;尿素などの低分子化合
物;ヒアルロン酸、コラーゲン、エラスチン、ポリエチ
レングリコール、ポリアクリル酸等の天然あるいは合成
の水溶性高分子が挙げられる。これらはそれぞれ単独あ
るいは複合して用いられているが、製品安定性への影
響、溶解性、使用感あるいは価格の点等で一長一短があ
る。
[0003] Commonly used humectants include organic acid salts such as sodium lactate and sodium pyrrolidone carboxylate; polyhydric alcohols such as glycerin, sorbitol and propylene glycol; low molecular weight compounds such as urea; hyaluronic acid; And natural or synthetic water-soluble polymers such as elastin, polyethylene glycol and polyacrylic acid. These are used singly or in combination, but each has advantages and disadvantages in terms of effects on product stability, solubility, usability, and price.

【0004】これまで医療用保湿剤としては、乾皮症の
治療を目的として10〜20%の尿素を含有したローシ
ョンまたはクリーム製剤が上市されている。これらの尿
素製剤は損傷のない皮膚に塗布した場合には、高い保湿
性を発揮して、大変有用であるが、老人性皮膚掻痒症や
アトピー性皮膚炎などの場合のように症状としてかゆみ
を伴い、その結果として皮膚に損傷がある場合には塗布
部位に著しい疼痛をもたらす。掻痒を伴うこれら症状の
患者は近時激増しているにもかかわらず適切な医療用保
湿性皮膚保護剤は開発されていない。
[0004] As a moisturizer for medical use, a lotion or cream preparation containing 10 to 20% urea has been put on the market for the purpose of treating xerosis. These urea preparations, when applied to intact skin, exhibit high moisturizing properties and are very useful, but may cause itching as symptoms such as senile pruritus and atopic dermatitis. As a result, if there is damage to the skin, it causes significant pain at the application site. Despite the recent rapid increase in patients with these symptoms accompanied by pruritus, no suitable medical moisturizing skin protectant has been developed.

【0005】一方化粧品の分野では尿素等の刺激性の強
い保湿剤は、ほとんど使用されずもっぱらヒアルロン
酸、コラーゲン、エラスチン等の水溶性天然高分子化合
物が利用されている。これら水溶性天然高分子化合物は
適当な保湿性を有しているが原料価格が高価であり、ま
た造膜性に乏しいため長時間べたつき感が残る欠点があ
る。
On the other hand, in the field of cosmetics, highly stimulating humectants such as urea are hardly used, and water-soluble natural high molecular compounds such as hyaluronic acid, collagen and elastin are used. These water-soluble natural polymer compounds have a suitable moisturizing property, but have a disadvantage that the raw material price is expensive and the film-forming property is poor, so that a sticky feeling remains for a long time.

【0006】近年、安価な天然高分子であるキトサン
は、その凝集性を活用して産業廃水処理剤として用いら
れる外、農産物発育促進剤として、あるいはその良好な
造膜性を利用して、水、エタノール分離膜としての応用
が考えられている。一方医療の分野でもキトサンを原料
として製造された皮膜が優れた皮膚生着性と静菌作用を
もつことから火傷などの損傷皮膚の被覆膜として使用さ
れている。
In recent years, chitosan, which is an inexpensive natural polymer, is used as an industrial wastewater treatment agent by utilizing its cohesiveness, and is also used as an agricultural product growth promoter or by utilizing its good film-forming properties. Its application as an ethanol separation membrane has been considered. On the other hand, also in the medical field, a film produced from chitosan as a raw material has excellent skin adhesion and bacteriostatic action, and is therefore used as a coating film for damaged skin such as burns.

【0007】以上のように優れた機能を有するキトサン
であるが、保湿剤として応用しようとする場合、重大な
問題点が生ずる。すなわち、キトサンは元来水不溶性の
塩基性高分子化合物であり、純水には不溶である。した
がってキトサン水溶液を得るには通常、無機酸または有
機酸水溶液にキトサンを溶解する方法がとられる。
Although chitosan has excellent functions as described above, serious problems arise when it is used as a humectant. That is, chitosan is a water-insoluble basic polymer compound by nature, and is insoluble in pure water. Therefore, in order to obtain an aqueous solution of chitosan, a method of dissolving chitosan in an aqueous solution of an inorganic acid or an organic acid is usually employed.

【0008】この場合、キトサンを稀乳酸、稀酢酸等に
数パーセント溶解した溶液は、健康な皮膚に塗布した場
合には極めて良好な使用感を与えるが、老人性皮膚掻痒
症やアトピー性皮膚炎などの場合のように皮膚に損傷が
ある場合には、溶液の酸性度が高い為、強い刺激感と疼
痛をもたらす。
In this case, a solution obtained by dissolving chitosan in diluted lactic acid, diluted acetic acid, etc. in a few percent gives an extremely good feeling of use when applied to healthy skin, but it has senile pruritus and atopic dermatitis. If the skin is damaged as in the case of the above, the acidity of the solution is high, resulting in strong irritation and pain.

【0009】この発明の目的は、キトサンを用いて、そ
の特性である保湿性を保持しつつ、極めて使用感が良好
で且つ安全性の高い皮膚保護剤を提供することにある。
[0009] It is an object of the present invention to provide a skin protective agent which uses chitosan and has a very good feeling in use and high safety while maintaining its characteristic moisturizing property.

【0010】[0010]

【課題を解決するための手段】上記の目的を達成するた
め鋭意研究を行った結果、(1)脱アセチル化率が75
%以上である高脱アセチル化キトサンが溶解性に優れ、
その中性溶液は刺激感がなく極めて使用感が良いこと、
(2)使用される高脱アセチル化キトサンとしては、そ
の生物起源も重要であり、カニ、エビ等の甲殻類由来の
キトサンはアレルギーを発症させるのに対してイカキト
サンはこのようなアレルギーを発症させずに安全性の面
から特に好ましいこと、を見い出し本発明を完成させ
た。
[Means for Solving the Problems] As a result of intensive studies to achieve the above object, (1) the deacetylation rate was 75.
% Highly deacetylated chitosan has excellent solubility,
The neutral solution has no irritation and is extremely comfortable to use.
(2) As for the highly deacetylated chitosan used, its biological origin is also important, whereas chitosan derived from crustaceans such as crab and shrimp causes allergies, whereas squid chitosan causes such allergies. The present invention has been completed by finding out that it is particularly preferable from the viewpoint of safety without doing so.

【0011】従って本発明は、脱アセチル化率が75%
以上であるイカキトサンの中性溶液からなることを特徴
とする皮膚保護剤を要旨とする。
[0011] Therefore, the present invention provides a deacetylation rate of 75%.
The gist is a skin protectant characterized by comprising a neutral solution of squid chitosan as described above.

【0012】[0012]

【発明の実施の形態】本発明の皮膚保護剤はキトサンの
中性溶液からなるものであり、キトサンは次の要件
(1)および(2)を満足するものである。
BEST MODE FOR CARRYING OUT THE INVENTION The skin protectant of the present invention comprises a neutral solution of chitosan, which satisfies the following requirements (1) and (2).

【0013】(1)脱アセチル化率が75%以上の高脱
アセチル化キトサンであること。 (2)生物起源がイカであるイカキトサンであること。
(1) Highly deacetylated chitosan having a deacetylation rate of 75% or more. (2) Squid chitosan whose biological origin is squid.

【0014】先ず脱アセチル化率に関する要件(1)に
ついて説明する。キトサンは水性溶媒に全く不溶性のキ
チンを原料とし、これを脱アセチル化して製造されてい
る。従ってキトサンは、式(a)
First, requirement (1) relating to the deacetylation rate will be described. Chitosan is produced by using chitin, which is completely insoluble in an aqueous solvent, as a raw material and deacetylating it. Therefore, chitosan is represented by the formula (a)

【化1】 で示されるN−アセチル化D−グルコサミン構成単位と
式(b)
Embedded image And an N-acetylated D-glucosamine structural unit represented by the formula:

【化2】 で示されるD−グルコサミン構成単位とが不規則に分布
しているものであり、構成単位(a)がアセチル化単
位、構成単位(b)が脱アセチル化単位である。従って
構成単位(a)および(b)中の構成単位(b)の割合
が脱アセチル化率である。
Embedded image And the D-glucosamine constitutional unit represented by are randomly distributed, the constitutional unit (a) is an acetylated unit, and the constitutional unit (b) is a deacetylated unit. Therefore, the ratio of the structural unit (b) in the structural units (a) and (b) is the deacetylation rate.

【0015】市場には脱アセチル化の程度に応じて脱ア
セチル化率が50〜90%程度の様々なタイプのキトサ
ンが供給されている。一方医療用保湿性皮膚保護剤ある
いは保湿性化粧品としてキトサンの水溶液を利用しよう
とした場合、皮膚に対する刺激感を生ぜしめない為に皮
膚のpH(4.5〜6.5)に適合した製剤とする必要
がある。これまで脱アセチル化率が50〜90%程度の
キトサンが希酸水溶液に可溶であることは公知である
が、これらのキトサンの、皮膚のpH(4.5〜6.
5)域に於ける溶解性については不明であった。本発明
者らは脱アセチル化率が50〜90%のキトサンについ
て種々の有機酸緩衝液(pH5.75:平均的な皮膚の
pH)に対する溶解性を検討した。
Various types of chitosan having a deacetylation rate of about 50 to 90% are supplied to the market depending on the degree of deacetylation. On the other hand, when trying to use an aqueous solution of chitosan as a medical moisturizing skin protective agent or moisturizing cosmetic, a formulation compatible with the pH of the skin (4.5 to 6.5) must be used in order not to cause irritation to the skin. There is a need to. It is known that chitosan having a deacetylation rate of about 50 to 90% is soluble in a dilute acid aqueous solution. However, the pH of these chitosans (4.5 to 6.
5) The solubility in the region was unknown. The present inventors examined the solubility of chitosan having a deacetylation ratio of 50 to 90% in various organic acid buffers (pH 5.75: average skin pH).

【0016】その結果、後掲の実験例1で示すように、
脱アセチル化率がそれぞれ53%、62%、69%であ
るキトサンを酢酸、乳酸、グルタミン酸、グリコール酸
の各水溶液に添加すると、いずれも白濁ないし沈殿が生
じるのに対し、脱アセチル化率がそれぞれ80%、91
%であるキトサンを同様の酢酸、乳酸、グルタミン酸、
グリコール酸の各緩衝液に添加すると、いずれもキトサ
ンが有機酸緩衝液に透明に溶解することが明らかとなっ
た。
As a result, as shown in Experimental Example 1 below,
When chitosan having deacetylation rates of 53%, 62% and 69%, respectively, is added to each of the aqueous solutions of acetic acid, lactic acid, glutamic acid and glycolic acid, opacity or precipitation occurs, whereas the deacetylation rates are respectively increased. 80%, 91
% Chitosan is similar to acetic acid, lactic acid, glutamic acid,
It was revealed that chitosan was transparently dissolved in the organic acid buffer when added to each glycolic acid buffer.

【0017】またこの脱アセチル化率が80%、91%
であるキトサンの乳酸、グルタミン酸、グリコール酸の
緩衝液は皮膚に適用したとき刺激感がなく極めて使用感
が良いことが明らかとなった。
The deacetylation rate is 80%, 91%
It has been clarified that the chitosan lactic acid, glutamic acid, and glycolic acid buffers have no irritating sensation when applied to the skin and are extremely comfortable to use.

【0018】これが、本発明においてキトサンの脱アセ
チル化率を75%以上に限定した理由である。キトサン
の脱アセチル化率は75〜98%が好ましく、80〜9
5%が特に好ましい。
This is the reason why the deacetylation rate of chitosan is limited to 75% or more in the present invention. The deacetylation rate of chitosan is preferably 75 to 98%, and 80 to 9%.
5% is particularly preferred.

【0019】次にキトサンの生物起源に関する要件
(2)について説明する。工業的にキトサンを得るため
のキチンの生物起源としてカニ、エビなどの甲殻類とイ
カがある。
Next, requirement (2) concerning the biological origin of chitosan will be described. Biological sources of chitin for industrially obtaining chitosan include crustaceans such as crab and shrimp and squid.

【0020】本発明者らは、後掲の実験例2で示すよう
に、カニ、エビなどの甲殻類由来のキチンの脱アセチル
化により得られたキトサンおよびイカ由来のキチンの脱
アセチル化により得られたキトサンの有機酸緩衝液を用
いてパッチ試験を行ない、皮膚のアレルギーの発生の有
無を観察し、安全性を評価した。用いたキトサンはカニ
由来のものが脱アセチル化率91%、エビ由来のものが
脱アセチル化率85%、イカ由来のものが脱アセチル化
率90%のものであり、また有機酸緩衝液としてグルタ
ミン酸緩衝液を用いた。
As shown in Experimental Example 2 below, the present inventors have obtained chitosan obtained by deacetylation of chitin derived from crustaceans such as crab and shrimp, and chitin derived from squid and obtained by deacetylation of chitin derived from squid. A patch test was performed using the obtained organic acid buffer of chitosan, and the occurrence of skin allergy was observed to evaluate the safety. The chitosan used was a crab-derived one having a deacetylation rate of 91%, a shrimp-derived one having a deacetylation rate of 85%, a squid-derived one having a deacetylation rate of 90%, and used as an organic acid buffer. Glutamate buffer was used.

【0021】その結果、カニおよびエビ由来のキトサン
の場合、被験者の中から皮膚に発赤を示した者が認めら
れたのに対し、イカ由来のキトサンの場合、被験者に発
赤を示した者は認められなかった。これが、本発明にお
いてキトサンの生物起源をイカに限定した理由である。
As a result, in the case of chitosan derived from crab and shrimp, some subjects exhibited redness on the skin, whereas in the case of chitosan derived from squid, those exhibiting redness in the subject were observed. I couldn't. This is the reason for limiting the biological origin of chitosan to squid in the present invention.

【0022】本発明の皮膚保護剤は、キトサンの中性溶
液からなり、該キトサンとして、上記要件(1)および
(2)を満足するものを用いることにより、キトサンが
本来保有する保湿性を有するとともに、皮膚に適用した
ときに刺激感がなく極めて使用感が良く、またアレルギ
ーを発症させないという顕著な技術的効果を奏する。
The skin protectant of the present invention comprises a neutral solution of chitosan, and by using a chitosan which satisfies the above requirements (1) and (2), it has the moisturizing property originally possessed by chitosan. At the same time, when applied to the skin, there is no feeling of irritation, the feeling of use is extremely good, and there is a remarkable technical effect of not causing allergies.

【0023】なお、本発明の皮膚保護剤を構成するキト
サンの中性溶液における「中性溶液」とは、通常の人間
の皮膚のpH域であるpHが4.5〜6.5の溶液を意
味する。
The "neutral solution" in the neutral solution of chitosan constituting the skin protectant of the present invention is a solution having a pH of 4.5 to 6.5 which is the pH range of normal human skin. means.

【0024】本発明の皮膚保護剤は、これに限定される
ものではないが、次のような方法で製造される。
The skin protective agent of the present invention is produced by, but not limited to, the following method.

【0025】(a)脱アセチル化率が75%以上のイカ
キトサンを0.01〜5wt%の有機酸緩衝液に溶解する
方法 (b)脱アセチル化率が75%以上のイカキトサンを
0.01〜5wt%の有機酸緩衝溶液に溶解したのち、こ
れにアルカリ水溶液を加えて中性とする方法 (c)脱アセチル化率が75%以上のイカキトサンをア
ルカリ水溶液に分散させて、十分に水和させたのち、
0.01〜5wt%の有機酸を加えて溶解させて中性水溶
液とする方法 上記方法(a),(b)および(c)で用いる有機酸と
しては、グリコール酸、乳酸、リンゴ酸、クエン酸、酒
石酸、グルコン酸、グルクロン酸、アスコルビン酸など
の水酸基含有カルボン酸;グルタミン酸、アスパラキン
酸などの酸性アミノ酸;パイログルタミン酸などのピロ
リドンカルボン酸などが挙げられる。有機酸として、そ
の塩を用いてもよい。
(A) A method of dissolving squid chitosan having a deacetylation rate of 75% or more in an organic acid buffer solution of 0.01 to 5% by weight. A method of dissolving in an organic acid buffer solution of 01 to 5 wt% and adding an aqueous alkaline solution to neutralize the solution. (C) Dispersing squid chitosan having a deacetylation ratio of 75% or more in an aqueous alkaline solution, After hydration,
Method of adding and dissolving 0.01 to 5% by weight of an organic acid to form a neutral aqueous solution The organic acids used in the above methods (a), (b) and (c) include glycolic acid, lactic acid, malic acid and citric acid. Examples include hydroxyl group-containing carboxylic acids such as acid, tartaric acid, gluconic acid, glucuronic acid, and ascorbic acid; acidic amino acids such as glutamic acid and aspartic acid; and pyrrolidone carboxylic acids such as pyrologglutamic acid. As the organic acid, a salt thereof may be used.

【0026】なお、酢酸、プロピオン酸などの低級脂肪
酸を用いた緩衝液はpH5〜6でも酸臭があるので、余
り好ましくない。中級および高級脂肪酸は溶解の点で使
用できない。アミノ酸のうち、中性アミノ酸、塩基性ア
ミノ酸は、中性域でキトサンが溶解しないため、使用で
きない。
A buffer using a lower fatty acid such as acetic acid or propionic acid is not preferred because it has an acidic odor even at pH 5-6. Intermediate and higher fatty acids cannot be used in terms of dissolution. Among amino acids, neutral amino acids and basic amino acids cannot be used because chitosan does not dissolve in the neutral region.

【0027】また方法(b)および(c)で用いるアル
カリとしては、水酸化ナトリウム、水酸化カリウム、リ
ン酸水素二ナトリウム、リン酸ナトリウム、炭酸カリウ
ム、炭酸ナトリウム、ホウ酸ナトリウムなどが挙げられ
る。
The alkali used in the methods (b) and (c) includes sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium phosphate, potassium carbonate, sodium carbonate, sodium borate and the like.

【0028】上記方法(a),(b)および(c)にお
けるイカキトサンの溶解操作は特に限定的なものでなく
任意の操作を採用できる。溶解を促進するために、撹拌
その他の機械的手段および加温するなどの物理的手段を
講じてよいことはもちろんである。
The dissolving operation of squid chitosan in the above methods (a), (b) and (c) is not particularly limited, and any operation can be adopted. Of course, physical measures such as stirring and other mechanical means and warming may be taken to promote dissolution.

【0029】方法(a),(b)および(c)におい
て、本発明の目的を損なわない範囲で、その他の添加剤
を加えることができる。
In the methods (a), (b) and (c), other additives can be added as long as the object of the present invention is not impaired.

【0030】[0030]

【実施例】以下、実験例、実施例および試験例に基いて
本発明を更に説明する。
The present invention will be further described below with reference to experimental examples, examples and test examples.

【0031】実験例1 キトサンの脱アセチル化率と有機酸緩衝液中での溶解性
との関係を調べた。
Experimental Example 1 The relationship between the deacetylation rate of chitosan and the solubility in an organic acid buffer was examined.

【0032】脱アセチル化率が53%、62%、69
%、80%、91%であるイカキトサンサンプルA、
B、C、D、Eを用い、各キトサンサンプルを酢酸、乳
酸、グルタミン酸、グリコール酸の各緩衝液(pH=
5.75)中に、キトサン濃度が1wt%となるように添
加し、各キトサンサンプルの溶解性を試験した。その結
果を表1に示す。表1より、脱アセチル化率が53%、
62%、69%であるキトサンサンプルA、B、Cの場
合、全ての有機酸緩衝液中で白濁、沈殿が発生するのに
対し、脱アセチル化率が80%、91%であるキトサン
サンプルD、Eは全ての有機酸緩衝液中で透明に溶解し
た。
Deacetylation rate is 53%, 62%, 69
%, 80%, 91% squid chitosan sample A,
Using B, C, D, and E, each chitosan sample was buffered with acetic acid, lactic acid, glutamic acid, and glycolic acid (pH =
5.75), the chitosan concentration was 1 wt%, and the solubility of each chitosan sample was tested. Table 1 shows the results. From Table 1, the deacetylation rate is 53%,
In the case of chitosan samples A, B and C having 62% and 69%, opacity and precipitation occur in all organic acid buffers, whereas chitosan sample D having deacetylation rates of 80% and 91%. , E dissolved transparently in all organic acid buffers.

【0033】[0033]

【表1】 [Table 1]

【0034】また溶解性に優れていた、脱アセチル化率
80%、91%のキトサンサンプルD、Eは、皮膚に適
用しても刺激感がなく極めて使用感が良いことが明らか
となった。
It was also found that the chitosan samples D and E, which were excellent in solubility and had a deacetylation ratio of 80% and 91%, had no irritating sensation even when applied to the skin and had a very good usability.

【0035】実験例2 キトサンの生物起源と安全性との関係を調べた。 Experimental Example 2 The relationship between the biological origin of chitosan and safety was examined.

【0036】カニ由来のキトサンサンプルF(脱アセチ
ル化率89%)を1%含むグルタミン酸緩衝溶液(pH
=5.75)を用いてパッチ試験を行ない、安全性を次
のように評価した。
A glutamate buffer solution (pH: 1%) containing 1% of crab-derived chitosan sample F (deacetylation rate: 89%)
= 5.75), and the safety was evaluated as follows.

【0037】19才から58才の男女18人の上腕部内
側にカニキトサン水溶液1gを塗布し、24時間後に皮
膚の状況を観察した。その結果、カニキトサン水溶液の
場合、22才の女性Aにやや強度の発赤を、53才の男
性Bに軽度の発赤を認めた。
An aqueous solution of canikytosan (1 g) was applied to the inside of the upper arm of 18 males and females aged 19 to 58, and the condition of the skin was observed 24 hours later. As a result, in the case of the aqueous solution of canikitosan, slightly strong redness was observed in female A at the age of 22 and mild redness at male B at the age of 53.

【0038】問診の結果、女性Aはエビ、カニ、アミ等
の甲殻類を食した場合、アレルギーを発症する体質であ
ることが判明した。男性Bは特に自覚症状としてエビ、
カニに対するアレルギーはなかった。
As a result of the interview, it was found that female A had a constitution that would cause allergies when eating crustaceans such as shrimp, crab, and mysid. Male B has shrimp as a subjective symptom,
There were no allergies to the crab.

【0039】さらにエビ由来のキトサンサンブルG(脱
アセチル化率85%)、イカ由来のキトサンサンブルE
(脱アセチル化率91%)を各1%含むグルタミン酸緩
衝液(pH5.75)を用いて、上記女性Aおよび男性
Bに対して、同様にパッチ試験を実施した。結果は表2
に示す。
Further, chitosan samble G derived from shrimp (deacetylation rate 85%), chitosan samble E derived from squid
A patch test was similarly performed on the female A and male B using a glutamate buffer (pH 5.75) containing 1% of each (deacetylation rate 91%). Table 2 shows the results
Shown in

【0040】表2より、エビ由来キトサンサンプルGの
場合、女性A、男性Bともに発赤を生じているのに対
し、イカ由来キトサンサンプルEの場合、キトサンを含
まないグルタミン酸緩衝液であるサンプルHと同様に、
女性A、男性Bともに発赤を生じず正常であった。
As shown in Table 2, shrimp-derived chitosan sample G caused redness in both female A and male B, whereas squid-derived chitosan sample E exhibited a glutamic acid buffer sample H containing no chitosan. Similarly,
Both female A and male B were normal without redness.

【0041】以上の結果から、従来から汎用されてきた
カニ、エビ等の甲殻類由来のキトサンはかなりの頻度で
アレルギーを発症させるのに対し、イカキトサンは更な
る43名の追加パッチ試験の結果でもなんら異常は認め
られず保湿性皮膚保護剤及び保湿性化粧品として極めて
優れていることが明らかとなった。
From the above results, while chitosan derived from crustaceans such as crab and shrimp, which has been widely used, causes allergy at a considerable frequency, icaquitosan is the result of an additional patch test of 43 more persons. However, no abnormality was observed and it was revealed that the product was extremely excellent as a moisturizing skin protective agent and moisturizing cosmetic.

【0042】[0042]

【表2】 [Table 2]

【0043】実施例1(ローション1) グルタミン酸0.5gを温水100mlに溶解し、これに
イカキトサン(脱アセチル化率91%)1gを溶解させ
た。この溶液に撹拌しながら1規定水酸化ナトリウム水
溶液を添加してpHを5.75としてローション(粘度
250CP、20℃)を製した。
Example 1 (Lotion 1) 0.5 g of glutamic acid was dissolved in 100 ml of warm water, and 1 g of squid chitosan (91% deacetylation rate) was dissolved therein. A 1N aqueous sodium hydroxide solution was added to this solution while stirring to adjust the pH to 5.75, and a lotion (viscosity 250 CP, 20 ° C.) was produced.

【0044】実施例2(ローション2) 乳酸ナトリウム0.3gを水100mlに溶解し、これに
イカキトサン(脱アセチル化率91%)1gを分散させ
た。該分散液に撹拌しながら乳酸を滴下してpHを5.
75に調節したのち、さらに撹拌を続けてキトサンを溶
解させローション(粘度280CP、20℃)を製し
た。
Example 2 (Lotion 2) 0.3 g of sodium lactate was dissolved in 100 ml of water, and 1 g of squid chitosan (91% deacetylation rate) was dispersed therein. Lactic acid was added dropwise to the dispersion with stirring to adjust the pH to 5.
After adjusting to 75, the mixture was further stirred to dissolve the chitosan to produce a lotion (viscosity: 280 CP, 20 ° C.).

【0045】実施例3(ローション3) 0.3Mグリコール酸緩衝液(pH5.60)100ml
にイカキトサン(脱アセチル化率91%)1gを加え撹
拌、溶解させてローション(粘度320CP、20℃)
を製した。
Example 3 (Lotion 3 ) 100 ml of 0.3 M glycolic acid buffer (pH 5.60)
1 g of squid chitosan (91% deacetylation rate) was added, stirred and dissolved to give a lotion (viscosity: 320 CP, 20 ° C.)
Was manufactured.

【0046】実施例4(クリーム) 実施例1のイカキトサン水溶液 39.5% 流動パラフィン 33.0 ワセリン 6.0 ラノリン 5.0 プロピレングリコール 5.0 固形パラフィン 3.0 グリセリンモノステアレート 2.5 ポリオキシエチレンソルビタンモノステアレート 2.5 ステアリルアルコール 2.0 香料 0.5 酸化防止剤及び防腐剤 適量 以上を用いて常法によりモイスチャークリームを製し
た。
Example 4 (Cream) 39.5% aqueous solution of squid chitosan of Example 1 Liquid paraffin 33.0 Vaseline 6.0 Lanolin 5.0 Propylene glycol 5.0 Solid paraffin 3.0 Glycerin monostearate 2.5 Polyoxyethylene sorbitan monostearate 2.5 Stearyl alcohol 2.0 Perfume 0.5 Antioxidant and preservative A suitable amount was used to prepare a moisture cream by a conventional method.

【0047】試験例1 実施例3で得たローションおよび同様にグリコール酸緩
衝液にヒアルロン酸(1wt%)を溶解したローションに
ついて皮膚角層水分計モデルSKICON−200(ア
イ・ビイ・エス社製)を用いて、その保温性を検討した
ところ、両者間にほとんど差異は認められなかった。次
に実施例3のローションとヒアルロン酸ローションを6
名の女性(20〜46才)に試用してもらい、その使用
感についてアンケート調査した。その結果を表3に示
す。
Test Example 1 Lotion obtained in Example 3 and a lotion obtained by dissolving hyaluronic acid (1 wt%) in a glycolic acid buffer solution in the same manner as above. Skin horny layer moisture meter model SKICON-200 (made by IBS) When the heat-retaining property was examined by using, the difference between the two was hardly recognized. Next, lotion of Example 3 and lotion of hyaluronic acid
We asked women (20 to 46 years old) to try it out and conducted a questionnaire survey on their feeling of use. Table 3 shows the results.

【0048】[0048]

【表3】 [Table 3]

【0049】試験例2 実施例1のイカキトサン水溶液を用いて実施例4で得た
クリームと、実施例1のイカキトサン水溶液の代りに4
0%尿素水溶液を用いた以外は実施例4と同様の処方に
よって製した尿素クリームを38才の両手指にアカギレ
のある女性にそれぞれ1週間患部に適宜塗布してもら
い、その使用感を聴取した。
Test Example 2 The cream obtained in Example 4 using the squid chitosan aqueous solution of Example 1 and 4 instead of the squid chitosan aqueous solution of Example 1 were used.
A urea cream prepared according to the same formulation as in Example 4 except that a 0% urea aqueous solution was used was applied to the affected part of a 38-year-old woman with red nails on both fingers for 1 week, and the feeling of use was heard. .

【0050】その結果 (i)比較の尿素クリームは塗布した瞬間から患部の痛み
が激しく、使用に耐えなかったので1回で中止した。 (ii)実施例4のイカキトサン含有クリームは刺激感が全
くなく、大きなヒビ割れにクリームが入っても全く痛み
を感じなかった。1日4〜6回の塗布を行ったところ、
細かなヒビは3日位で消失し、1週間後では大きなヒビ
もかなり小さくなり治癒効果がある。 との回答を得た。
Results (i) The comparative urea cream suffered severe pain from the moment of application and was unbearable for use, so it was stopped once. (ii) The cream containing squid chitosan of Example 4 had no irritation at all, and no pain was felt even when the cream entered a large crack. After applying 4-6 times a day,
Fine cracks disappear in about three days, and after one week, large cracks are considerably smaller and have a healing effect. I got the answer.

【0051】[0051]

【発明の効果】本発明によれば、キトサンを用いて、キ
トサンが本来有する保湿性を保持しつつ、極めて使用感
が良好で且つ安全性の高い皮膚保護剤およびその製造方
法が提供された。
According to the present invention, there is provided a skin protective agent which is extremely safe to use and highly safe while maintaining the inherent moisturizing properties of chitosan, and a method for producing the same.

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成7年10月25日[Submission date] October 25, 1995

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0047[Correction target item name] 0047

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0047】試験例1 実施例3で得たローションおよび同様にグリコール酸緩
衝液にヒアルロン酸(1wt%)を溶解したローションに
ついて皮膚角層水分計モデルSKICON−200(ア
イ・ビイ・エス社製)を用いて、その保湿性を検討した
ところ、両者間にほとんど差異は認められなかった。次
に実施例3のローションとヒアルロン酸ローションを6
名の女性(20〜46才)に試用してもらい、その使用
感についてアンケート調査した。その結果を表3に示
す。
Test Example 1 The lotion obtained in Example 3 and a lotion in which hyaluronic acid (1 wt%) was similarly dissolved in a glycolic acid buffer solution were used. Skin horny layer moisture meter model SKICON-200 (manufactured by IBS) When the moisturizing property was examined using, there was hardly any difference between the two. Next, lotion of Example 3 and lotion of hyaluronic acid
We asked women (20 to 46 years old) to try it out and conducted a questionnaire survey on their feeling of use. Table 3 shows the results.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 脱アセチル化率が75%以上であるイカ
キトサンの中性溶液からなることを特徴とする皮膚保護
剤。
1. A skin protective agent comprising a neutral solution of squid chitosan having a deacetylation rate of 75% or more.
【請求項2】 脱アセチル化率が75%以上であるイカ
キトサンを0.01〜5wt%の有機酸緩衝水溶液に溶解
することを特徴とする、請求項1に記載の皮膚保護剤の
製造方法。
2. The method for producing a skin protective agent according to claim 1, wherein squid chitosan having a deacetylation ratio of 75% or more is dissolved in a 0.01 to 5% by weight aqueous solution of an organic acid buffer. .
【請求項3】 脱アセチル化率が75%以上であるイカ
キトサンを0.01〜5wt%の有機酸水溶液に溶解した
のち、これにアルカリ性水溶液を加えて中性とすること
を特徴とする請求項1に記載の皮膚保護剤の製造方法。
3. A method of dissolving squid chitosan having a deacetylation rate of 75% or more in a 0.01 to 5% by weight aqueous solution of an organic acid, and adding an alkaline aqueous solution to the solution to make it neutral. Item 10. A method for producing the skin protective agent according to item 1.
【請求項4】 脱アセチル化率が75%以上であるイカ
キトサンをアルカリ性水溶液に分散させて、水和させた
のち、0.01〜5wt%の有機酸を加えて溶解させて中
性溶液とすることを特徴とする請求項1に記載の皮膚保
護剤の製造方法。
4. Ikachitosan having a deacetylation rate of 75% or more is dispersed in an alkaline aqueous solution, hydrated, and then dissolved by adding 0.01 to 5% by weight of an organic acid to form a neutral solution. The method for producing a skin protective agent according to claim 1, wherein
JP7267359A 1995-10-16 1995-10-16 Skin protective agent and method for producing the same Expired - Fee Related JP2790786B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7267359A JP2790786B2 (en) 1995-10-16 1995-10-16 Skin protective agent and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7267359A JP2790786B2 (en) 1995-10-16 1995-10-16 Skin protective agent and method for producing the same

Publications (2)

Publication Number Publication Date
JPH09110634A true JPH09110634A (en) 1997-04-28
JP2790786B2 JP2790786B2 (en) 1998-08-27

Family

ID=17443734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7267359A Expired - Fee Related JP2790786B2 (en) 1995-10-16 1995-10-16 Skin protective agent and method for producing the same

Country Status (1)

Country Link
JP (1) JP2790786B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190694B1 (en) 1999-04-05 2001-02-20 Toshio Satoh Chitosan-containing soft capsule and process for producing the same
JP2002069101A (en) * 2000-09-01 2002-03-08 Kyowa Technos:Kk Near neutral aqueous chitosan solution, its dried product, and method of producing them
EP1189584A1 (en) * 1999-05-18 2002-03-27 Marvin E. Klein Alpha amino acid composition and method for the treatment of skin
KR100691869B1 (en) * 2004-07-01 2007-03-12 주식회사 바이오폴 A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex
EP1816474A1 (en) * 2004-11-25 2007-08-08 DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. Method of determining tropomyosin in chitosan

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101591470B1 (en) * 2014-11-19 2016-02-03 제너럴바이오(주) A composition for chitosan solution thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02292301A (en) * 1989-05-02 1990-12-03 Nippon Suisan Kaisha Ltd Production of chitosan salt

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02292301A (en) * 1989-05-02 1990-12-03 Nippon Suisan Kaisha Ltd Production of chitosan salt

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190694B1 (en) 1999-04-05 2001-02-20 Toshio Satoh Chitosan-containing soft capsule and process for producing the same
EP1189584A1 (en) * 1999-05-18 2002-03-27 Marvin E. Klein Alpha amino acid composition and method for the treatment of skin
EP1189584A4 (en) * 1999-05-18 2006-01-25 Cosmeceuticals Inc Excel Alpha amino acid composition and method for the treatment of skin
JP2002069101A (en) * 2000-09-01 2002-03-08 Kyowa Technos:Kk Near neutral aqueous chitosan solution, its dried product, and method of producing them
KR100691869B1 (en) * 2004-07-01 2007-03-12 주식회사 바이오폴 A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex
EP1816474A1 (en) * 2004-11-25 2007-08-08 DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. Method of determining tropomyosin in chitosan
EP1816474A4 (en) * 2004-11-25 2008-04-02 Dainichiseika Color Chem Method of determining tropomyosin in chitosan

Also Published As

Publication number Publication date
JP2790786B2 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
KR101217382B1 (en) EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE
US5876744A (en) Highly bioadhesive and mucoadhesive compositions containing polyvinyl alcohol, polycarbophil and biopolymer for the treatment of skin conditions and as vehicles for active ingredients
KR100945971B1 (en) Acidic composition for external use, and agent for accelerating penetration into the skin or the like of cosmetic preparation, hair-growing agent and preparation for external use each containing the composition
KR20130018739A (en) Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
JPH1121247A (en) Skin activator and allergy inhibitor
JPH08208488A (en) Skin preparation for external use
JP2965322B2 (en) External preparation for skin
JP2790786B2 (en) Skin protective agent and method for producing the same
CN110917120A (en) Sticky antibacterial repairing material and preparation method and application thereof
JPH03204804A (en) Skin cosmetic
JPH01275511A (en) External drug for skin
JPH069422A (en) Promoter for biosynthesis of hyaluronic acid
JPS5869806A (en) Cosmetic lotion containing stable collagen
JP2001233755A (en) Skin care preparation composition
JPH09227387A (en) Drug externally using for treatment of atopic dermatitis
JPH01117815A (en) External preparation for skin
JPH09291013A (en) Skin cosmetic material
JPH09176034A (en) Preparation for external use for skin
JPH05301812A (en) Skin external preparation
JP3202790B2 (en) Novel chitosan derivatives and their uses
JPH06279294A (en) Collagen synthesis promoter
KR20220027633A (en) Cosmetic Composition Containing LHA Crystal Pearl Effective For Improving Skin Trouble
JPH11349470A (en) Composition for external use
WO2009032325A1 (en) Shaped items containing a human pheromone component
JPH08283138A (en) Skin cosmetic

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19980526

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090612

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100612

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110612

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120612

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130612

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140612

Year of fee payment: 16

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees